These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11882074)

  • 1. Management of spontaneous inhibitors in children with porcine factor VIII.
    Kobrinsky NL; Stegman D; Sjolander D
    Haemophilia; 2002 Jan; 8 Suppl 1():1-4; discussion 28-32. PubMed ID: 11882074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine factor VIII in the treatment of high-titre inhibitor patients.
    Garvey MB
    Haemophilia; 2002 Jan; 8 Suppl 1():5-8; discussion 28-32. PubMed ID: 11882075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Protein-A column and porcine factor VIII.
    Rivard GE
    Haemophilia; 2002 Jan; 8 Suppl 1():20-3; discussion 28-32. PubMed ID: 11882079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor.
    Croteau SE; Abajas YL; Wolberg AS; Nielsen BI; Marx GR; Baird CW; Neufeld EJ; Monahan PE
    Haemophilia; 2017 Mar; 23(2):e93-e98. PubMed ID: 28124406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.
    Ashrani AA; Reding MT; Greeno EW; Shet A; Key NS
    Haemophilia; 2002 Jan; 8(1):56-8. PubMed ID: 11886466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.
    Gribble J; Garvey MB
    Haemophilia; 2000 Sep; 6(5):482-5. PubMed ID: 11012689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII.
    Green D; Blanc J; Foiles N
    J Lab Clin Med; 1999 Mar; 133(3):260-4. PubMed ID: 10072258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired anti-FVIII inhibitors in children.
    Moraca RJ; Ragni MV
    Haemophilia; 2002 Jan; 8(1):28-32. PubMed ID: 11886462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
    Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII.
    Parker ET; Craddock HN; Barrow RT; Lollar P
    J Thromb Haemost; 2004 Apr; 2(4):605-11. PubMed ID: 15102015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to factor VIII with catalytic activity.
    Bayry J; Lacroix-Desmazes S; Pashov A; Stahl D; Hoebeke J; Kazatchkine MD; Kaveri SV
    Autoimmun Rev; 2003 Jan; 2(1):30-5. PubMed ID: 12848973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.